| General Information of Drug Metabolite (DM) (ID: DM019482) |
| DM Name |
L-FMAUDP
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Thymidine kinase (TK1)
|
DMEN825
|
| Unclear - Unclear |
Clevudine
|
[1] |
|
Thymidine kinase 2 (TK2)
|
DMEN045
|
| Unclear - Unclear |
Clevudine
|
[1] |
|
|
|
|
|
|
|
| DME(s) Metabolizing This DM |
| DME Name |
DME ID |
Product |
Reaction |
Related Drug |
REF |
|
Phosphoglycerate kinase 2 (PGK2)
|
DMEN005
|
| Unclear - Unclear |
Clevudine
|
[1] |
|
Thymidylate kinase (DTYMK)
|
DME0415
|
| Unclear - Unclear |
Clevudine
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Clevudine |
DR3533
|
Phase 3 |
Hepatitis B virus infection |
|
|
| References |
| 1 |
Circulating purine compounds, uric acid, and xanthine oxidase/dehydrogenase relationship in essential hypertension and end stage renal disease. Ren Fail. 2014 May;36(4):613-8. doi: 10.3109/0886022X.2014.882240.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
